Atlas Trials

A Phase 2 Influenza A Challenge Study Following Oral Administration of an H1N1 HA Ad-Vector Seasonal Flu Vaccine

Clinical trial NCT02918006 · COMPLETED

Trial details

NCT number
NCT02918006
Sponsor
Vaxart
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Influenza
Start date
2016-08-31
Primary completion
2017-08-08
Enrollment
179

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.